Eik Bjerre

Suggest Changes
  • Citations Per Year
Learn More
Prostate cancer is the most common non-cutaneous malignancy in men. Today most patients may expect to live years following the diagnosis and may thus experience significant morbidity due to disease(More)
BACKGROUND The minimum clinically important difference (MCID) is used to interpret the relevance of treatment effects, e.g. when developing clinical guidelines, evaluating trial results or planning(More)
  • 1